EPC080 Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years' evidence summaryE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC081 Clinical and demographic characteristics of tuberculosis patients in health care facilities in Botswana: a retrospective analysisE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC082 Declining trends of HIV and syphilis seroprevalence at integrated counselling and testing centre in a tertiary care hospital in North India: a six year studyE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC083 Prevalence of non-communicable diseases among HIV-infected persons in sub-Saharan Africa: a systematic reviewE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC084 High prevalence of anal high-risk human papillomavirus infectionin HIV-negative French men who have sex with men during 12 months of Pre-exposure prophylaxis uptake:potential efficacy of Gardasil-9® vaccinationE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC085 Scale-up of tuberculosis preventive therapy among people living with HIV in Uganda: initiation, completion, and TB disease notification rates, April 2017'September 2021E-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC086 HPV prevalence and risk factors in HIV-negative and HIV-positive South Africa adolescent girls: results from the HOPE studyE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
EPC087 High incidence of HIV and STIs in late pregnancy: compelling evidence for repeat etiological testingE-posterEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
OAC0203 The impact of COVID-19 non-pharmaceutical interventions on incidence and case-fatality ratios of sexually transmitted diseases in ChinaOral abstract session with live Q&AEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
PESAC11 Declining incidence of chlamydia and gonorrhea, but not mycoplasma in a high-risk population eligible for PrEP experiencing a test-and-treat-settingPoster exhibitionEpidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19)
1731 - 1740 of 2485 items